{Reference Type}: Journal Article
{Title}: Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.
{Author}: Fanlo P;Espinosa G;Adán A;Arnáez R;Fonollosa A;Heras H;Oteiza J;Del Carmelo Gracia Tello B;Sáez Comet L;Pallarés L;
{Journal}: Arch Soc Esp Oftalmol (Engl Ed)
{Volume}: 96
{Issue}: 7
{Year}: Jul 2021
暂无{DOI}: 10.1016/j.oftale.2020.12.007
{Abstract}: <B>BACKGROUND: </B>The objective of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey.<BR><B>METHODS: </B>Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population.<BR><B>RESULTS: </B>A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE. The majority (82%) were female and caucasian (82%), with a mean age of 48 years. The most frequent SAEs were Behçet's disease followed by sarcoidosis and systemic lupus erythematosus. 46% of the patients were receiving corticosteroid treatment at a mean prednisone dose of 11 mg/day. Regarding infection, 14 (50%) patients reported symptoms compatible with SARS-CoV-2 infection. RT-PCR was performed on the nasopharyngeal smear in two patients and in one of them (4%) it was positive.<BR><B>CONCLUSIONS: </B>Both asymptomatic and symptomatic COVID-19 patients with ASD-associated UNI had received similar immunosuppressive treatment.